TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27179731

Group type: EXPERIMENTAL
Intervention: Newer generation permanent polymer-coated drug-eluting stents (DES)
Number of subjects: 1423
Study: 25199531

Group type: EXPERIMENTAL
Intervention: Nine-month regimen including clofazimine and high-dose moxifloxacin (can be extended to 11 months if needed)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Control regimen as recommended by the World Health Organization (WHO) for MDR-TB
Number of subjects: 400
Study: 22897540

Group type: EXPERIMENTAL
Intervention: Young Parenthood Program (YPP), a 10-week counseling program administered during pregnancy
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 105
Study: 21311483

Group type: EXPERIMENTAL
Intervention: Pantogam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17980021

Group type: EXPERIMENTAL
Intervention: Group A practices (didactic training and course materials in oral health screening, referral, counseling, and application of fluoride varnish)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Group B practices (same as Group A + weekly conference calls providing advice and support)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Group C practices (same as Group B + in‐office visits providing hands‐on advice and support)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Group A practices
Number of subjects: 121

Group type: COMPARATOR
Intervention: Group B practices
Number of subjects: 121

Group type: COMPARATOR
Intervention: Group C practices
Number of subjects: 121
Study: 15817595

Group type: EXPERIMENTAL
Intervention: Letrozole 2.5 mg taken daily for 5 years
Number of subjects: 347

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 347
Study: 12226607

Group type: COMPARATOR
Intervention: Transbond XT primer and adhesive applied to a noncontaminated surface
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Assure primer applied after saliva contamination
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: MIP primer applied after saliva contamination
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Assure primer reapplied after saliva contamination
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: MIP reapplied after saliva contamination
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Assure adhesive applied after saliva contamination of the primer
Number of subjects: 240
Study: 10374174

Group type: EXPERIMENTAL
Intervention: 1 U/kg/week of recombinant GH
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group, no treatment
Number of subjects: 30
Study: 7786929

Group type: EXPERIMENTAL
Intervention: Neurofeedback training (2-3 months, targeting 16-20 Hz beta activity and reducing 4-8 Hz theta activity)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Neurofeedback training
Number of subjects: 23
Study: 2133014

Group type: COMPARATOR
Intervention: Milrinone (12.5 to 75 microns/kg, intravenously)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Milrinone (at rest)
Number of subjects: 15
Study: 374692

Group type: EXPERIMENTAL
Intervention: Large amounts of ascorbic acid, niacinamide, calcium pantothenate, and pyridoxine added to a low carbohydrate-high protein diet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Diet alone (control)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Parent-administered behavior checklist (regardless of group assignment)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Urinary excretion of kryptopyrrole
Number of subjects: 20
Study: 31808514

Group type: EXPERIMENTAL
Intervention: Nomogram based on expanded TNM staging
Number of subjects: 595

Group type: COMPARATOR
Intervention: TNM staging system
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 595
Study: 29289934

Group type: EXPERIMENTAL
Intervention: Umbilical cord clamping at 60 seconds
Number of subjects: 200

Group type: COMPARATOR
Intervention: Umbilical cord clamping at 10 seconds
Number of subjects: 200

Group type: COMPARATOR
Intervention: Umbilical cord clamping at 180 seconds
Number of subjects: 200
Study: 25761786

Group type: EXPERIMENTAL
Intervention: Low erosive blackcurrant drink
Number of subjects: 21

Group type: COMPARATOR
Intervention: Commercially available conventional apple and blackcurrant fruit juice drink
Number of subjects: 21

Group type: COMPARATOR
Intervention: Mineral water
Number of subjects: 21
Study: 23132732

Group type: EXPERIMENTAL
Intervention: Standardized humor therapy group
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group with no treatment
Number of subjects: 99
Study: 20676689

Group type: EXPERIMENTAL
Intervention: Laparoscopic adjustable silicone gastric banding (LASGB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Laparoscopic vertical banded gastroplasty (LVBG)
Number of subjects: 100
Study: 19856521

Group type: EXPERIMENTAL
Intervention: Two doses of A/Vietnam/1194/2004 given 6 months apart
Number of subjects: 48

Group type: COMPARATOR
Intervention: Two doses of A/Vietnam/1194/2004 given 21 days apart
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: A/Indonesia/05/2005 booster dose after one primary dose of A/Vietnam/1194/2004
Number of subjects: 48
Study: 16740843

Group type: EXPERIMENTAL
Intervention: Iron-fortified rice meal (approximately 15 mg of iron per day as ferric pyrophosphate)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control meal without added iron
Number of subjects: 186
Study: 15634526

Group type: EXPERIMENTAL
Intervention: High dose impulsion chemotherapy (HDIC)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Low dose density chemotherapy (LDDC)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Comparison of HDIC and LDDC
Number of subjects: 126
Study: 11706624

Group type: EXPERIMENTAL
Intervention: Surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Surgery only (Control)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Surgery plus IHCP
Number of subjects: 103
Study: 8990427

Group type: EXPERIMENTAL
Intervention: 15-methyl prostaglandin F2 alpha (250 micrograms, intramuscularly every 20 minutes, maximum three doses)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo (normal saline, intramuscularly every 20 minutes, maximum three doses)
Number of subjects: 67
Study: 8302395

Group type: EXPERIMENTAL
Intervention: cilazapril
Number of subjects: 22

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 22
Study: 3525273

Group type: EXPERIMENTAL
Intervention: Oral ketoconazole (400 mg for 5 days)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Topical miconazole (1200 mg a single dose)
Number of subjects: 42
Study: 30281652

Group type: EXPERIMENTAL
Intervention: High Activity prosthesis
Number of subjects: 22

Group type: COMPARATOR
Intervention: Low Activity prosthesis
Number of subjects: 22
Study: 27903389

Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg
Number of subjects: 541

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 541
Study: 24506479

Group type: EXPERIMENTAL
Intervention: Color Record (CR)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Color Display (CD)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Non-Color Record (non-CR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Non-Color Display (non-CD)
Number of subjects: 120
Study: 21558457

Group type: EXPERIMENTAL
Intervention: Isoniazid 10 to 20 mg/kg/d orally
Number of subjects: 151
Study: 19616987

Group type: EXPERIMENTAL
Intervention: 40 mg/day istradefylline
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 18392461

Group type: EXPERIMENTAL
Intervention: Postoperative pleural drainage for 3 hours
Number of subjects: 56

Group type: COMPARATOR
Intervention: No postoperative pleural drainage
Number of subjects: 56
Study: 15883317

Group type: EXPERIMENTAL
Intervention: AN1792/QS-21 (225 mug plus QS-21 50 mug)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 372
Study: 12813116

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) plus SSRIs when indicated, initiated at a median of 17 days after MI for a median of 11 sessions over 6 months.
Number of subjects: 2481

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 2481

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) plus SSRIs when indicated
Number of subjects: 2481
Study: 11069801

Group type: EXPERIMENTAL
Intervention: Respiratory muscle training (RMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Breathing exercises with an incentive spirometer (control)
Number of subjects: 30
Study: 9272925

Group type: EXPERIMENTAL
Intervention: NebuChamber (CFC-free MDI)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Turbuhaler (DPI)
Number of subjects: 10
Study: 8497020

Group type: EXPERIMENTAL
Intervention: Imagery training programme (visual and kinaesthetic imagery, internal and external perspectives), 6 weeks, bi-weekly sessions of 15 min each.
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (competitive strategy unrelated to performance task), 6 weeks, bi-weekly sessions of 15 min each.
Number of subjects: 44
Study: 3576125

Group type: EXPERIMENTAL
Intervention: Intragastric pH monitoring with an antimony electrode
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hourly aspiration of gastric juice
Number of subjects: 20
Study: 27694549

Group type: EXPERIMENTAL
Intervention: Socratic questioning-based sessions on ethics and moral dilemmas (experiment group 1)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: 4-hour workshop (experiment group 2)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 103
Study: 27244221

Group type: EXPERIMENTAL
Intervention: Recombinant human Bile Salt-Stimulated Lipase (rhBSSL)
Number of subjects: 415

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Recombinant human Bile Salt-Stimulated Lipase (rhBSSL) in small for gestational age infants
Number of subjects: 415

Group type: COMPARATOR
Intervention: Placebo in small for gestational age infants
Number of subjects: 415
Study: 25514519

Group type: EXPERIMENTAL
Intervention: Real-time neurofeedback training of alpha lateralization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham feedback (Control)
Number of subjects: 0
Study: 23866835

Group type: EXPERIMENTAL
Intervention: Granule group at 10 grams, three times daily (G10 group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Granule group at 20 grams, three times daily (G20 group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Decoction group (D group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Irbesartan group (Aprovel group)
Number of subjects: 48
Study: 21096598

Group type: EXPERIMENTAL
Intervention: Anisotropic diffusion tensor measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statistical learning scheme
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orientation of breast tissue changes
Number of subjects: 0
Study: 18796444

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 17165497

Group type: EXPERIMENTAL
Intervention: Moxibustion and acupuncture at Zusanli (ST 36) plus acupuncture at Hegu (LI 4), Taichong (LR 3), Touwei (ST 8)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acupuncture at Hegu (LI 4), Taichong (LR 3), Touwei (ST 8)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moxibustion and acupuncture at Zusanli (ST 36) with needling sensation propagating along the channel
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: No needling sensation propagating along the channel
Number of subjects: 60
Study: 14586349

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (100 microg every 6 hours to a maximum of two doses)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 305
Study: 11220772

Group type: EXPERIMENTAL
Intervention: Artemotil (ARTECEF)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Quinine
Number of subjects: 92
Study: 8814200

Group type: EXPERIMENTAL
Intervention: 70% amylopectin cornstarch
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 70% amylose cornstarch
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Excess energy intake (125% of maintenance energy)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: High amylose consumption
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: High amylopectin starch with excess energy intake
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: High amylose diet with excess energy intake
Number of subjects: 22
Study: 29455696

Group type: EXPERIMENTAL
Intervention: Regulating Emotions and Changing Habits (REaCH)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Supportive Psychotherapy
Number of subjects: 22
Study: 27595716

Group type: EXPERIMENTAL
Intervention: Modified Tandem Appliance (MTA)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Facemask (FM)
Number of subjects: 32
Study: 25611935

Group type: EXPERIMENTAL
Intervention: Traditional school schedule
Number of subjects: 168

Group type: COMPARATOR
Intervention: Modified block school schedule
Number of subjects: 168
Study: 23117076

Group type: EXPERIMENTAL
Intervention: Intervention effects assessed at 3.5 years post intervention
Number of subjects: 492

Group type: COMPARATOR
Intervention: Control group (no further intervention)
Number of subjects: 492
Study: 21359104

Group type: EXPERIMENTAL
Intervention: Cannabis use (A)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Cannabis abstinence (B/C)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Morning assessments during abstinence
Number of subjects: 13
Study: 18540736

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral relaxation training (RLXN)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Focused tai chi training (TCHI)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Spiritual growth groups (SPRT)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Wait-listed control group (CTRL)
Number of subjects: 252
Study: 16019795

Group type: EXPERIMENTAL
Intervention: Low-dose group (1.5 g/day)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High-dose group (3.0 g/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both groups (1.5 g/day and 3.0 g/day)
Number of subjects: 50
Study: 12383077

Group type: EXPERIMENTAL
Intervention: ERHOX (hyperoxic air during entire exercise and recovery)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: RHOX (hyperoxic air only during recovery)
Number of subjects: 9

Group type: COMPARATOR
Intervention: NOX (normoxia)
Number of subjects: 9
Study: 10515023

Group type: EXPERIMENTAL
Intervention: Cold intraoperative wound irrigation with a cold (18 C) 5% bacitracin solution for 5 minutes and postoperative wound cooling with a microtemperature pump for 24 hours.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard postoperative care without additional hypothermic therapy (control group).
Number of subjects: 70
Study: 7492035

Group type: EXPERIMENTAL
Intervention: Heated 2% lidocaine (42 degrees C)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Room-temperature 2% lidocaine (21 degrees C)
Number of subjects: 20
Study: 1837763

Group type: EXPERIMENTAL
Intervention: Short wave therapy (460 MHz, 50‐60 W, for 8‐20 minutes)
Number of subjects: 120
Study: 6782146

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium (CS) inhalant
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30107984

Group type: EXPERIMENTAL
Intervention: Depth jumps (DJ)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control condition (body weight quarter squats)
Number of subjects: 17
Study: 28067612

Group type: EXPERIMENTAL
Intervention: Priming group (negative aging stereotype activated)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no priming)
Number of subjects: 120
Study: 27136908

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg/day under fasted conditions (Period-1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Canagliflozin 300 mg/day under fed conditions (Period-2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Canagliflozin 50 mg, 100 mg, and 300 mg (in a 3-way crossover study)
Number of subjects: 0
Study: 24150778

Group type: EXPERIMENTAL
Intervention: BG-12 (dimethyl fumarate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21191850

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sample size calculation procedure
Number of subjects: 0
Study: 19318534

Group type: EXPERIMENTAL
Intervention: Mobile phone-based smoking cessation support intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Pooled effect estimate from txt2stop and STOMP trials
Number of subjects: 200
Study: 17673580

Group type: COMPARATOR
Intervention: Fondaparinux
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: Fondaparinux plus compression stockings
Number of subjects: 795
Study: 14748864

Group type: EXPERIMENTAL
Intervention: Intervention group (screening and treatment for depression by resident physicians)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Usual care group (provided results of the screen and advised to seek care)
Number of subjects: 61
Study: 11330928

Group type: EXPERIMENTAL
Intervention: DIAGNOdent device
Number of subjects: 240

Group type: COMPARATOR
Intervention: Traditional clinical methods
Number of subjects: 240
Study: 9213940

Group type: EXPERIMENTAL
Intervention: Taping and oral NSAID proglumetacine b.i.d. (26 patients)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Taping and oral placebo b.i.d. (22 patients)
Number of subjects: 48
Study: 8424422

Group type: EXPERIMENTAL
Intervention: Erythromycin 250 mg intravenously every 8 hours for nine doses
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 3300532

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Nalidixic acid
Number of subjects: 84
Study: 30937304

Group type: EXPERIMENTAL
Intervention: Intensive nutritional counseling (INC)
Number of subjects: 58

Group type: COMPARATOR
Intervention: On-demand nutritional counseling (ODC)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both INC and ODC
Number of subjects: 58
Study: 28253900

Group type: EXPERIMENTAL
Intervention: LOCI intervention (leadership training for workgroup leaders, ongoing implementation leadership coaching, 360° assessment, and strategic planning)
Number of subjects: 420

Group type: COMPARATOR
Intervention: Webinar leadership training control condition
Number of subjects: 420
Study: 25597529

Group type: EXPERIMENTAL
Intervention: Trigeminal nerve stimulation (TNS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 40
Study: 23438483

Group type: EXPERIMENTAL
Intervention: Adalimumab weekly dosing
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Adalimumab every other week (eow) dosing
Number of subjects: 498

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 498
Study: 21617556

Group type: EXPERIMENTAL
Intervention: Nerve block anesthesia at the wrist with 1% lidocaine followed by standard injection
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard injection alone using 1-needle 2-syringe technique with 0.5 mL 1% lidocaine and 20 mg triamcinolone acetonide
Number of subjects: 19
Study: 18433305

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation (2000 mg calcium and 800 IU vitamin D/d)
Number of subjects: 5201

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5201
Study: 17202633

Group type: EXPERIMENTAL
Intervention: Miltefosine (2.5 mg/Kg/day, orally, o.d. or b.i.d., max 100 mg)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Amphotericin B (1 mg/Kg/day, total 15 mg/Kg)
Number of subjects: 125
Study: 12783417

Group type: EXPERIMENTAL
Intervention: Interferon beta1a 22 microg subcutaneously once weekly
Number of subjects: 309
Study: 10189772

Group type: EXPERIMENTAL
Intervention: Experimental form of therapy of indeterminate benefit
Number of subjects: 654

Group type: EXPERIMENTAL
Intervention: Randomized clinical trial of two therapies
Number of subjects: 654
Study: 8610312

Group type: EXPERIMENTAL
Intervention: Increased common carotid intima-media thickness (CC-IMT)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Factor VII (FVII) levels
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: von Willebrand factor (vWF) levels
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Factor VII (FVII) as an independent variable
Number of subjects: 64
Study: 1928569

Group type: EXPERIMENTAL
Intervention: Levo-praziquantel (20 mg/kg)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Praziquantel (40 mg/kg)
Number of subjects: 278
Study: 6651596

Group type: EXPERIMENTAL
Intervention: 10% viscous solution of phenylephrine hydrochloride
Number of subjects: 3

Group type: COMPARATOR
Intervention: 2.5% aqueous solution of phenylephrine hydrochloride
Number of subjects: 3
Study: 30678193

Group type: EXPERIMENTAL
Intervention: Tart cherry juice (480 mL daily for 12 weeks)
Number of subjects: 37
Study: 29745970

Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Moderate Continuous Training (MCT)
Number of subjects: 110
Study: 28361746

Group type: EXPERIMENTAL
Intervention: Mediterranean-style diet for two months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study: 26583678

Group type: EXPERIMENTAL
Intervention: Laparoscopic Distal Pancreatectomy (LapDP)
Number of subjects: 2753

Group type: COMPARATOR
Intervention: Open Distal Pancreatectomy (OpenDP)
Number of subjects: 2753
Study: 23839181

Group type: EXPERIMENTAL
Intervention: Topical brimonidine tartrate gel 0.5%
Number of subjects: 2

Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 2
Study: 22379915

Group type: EXPERIMENTAL
Intervention: PCA with trimeperidine and ketoprofen
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: PCA with only trimeperidine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ketoprofen combined with intramuscular injection of trimeperidine
Number of subjects: 75
Study: 18571251

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Bare metal stents (BMS)
Number of subjects: 96
Study: 16461817

Group type: EXPERIMENTAL
Intervention: ICD therapy
Number of subjects: 458

Group type: COMPARATOR
Intervention: Standard medical therapy (STD)
Number of subjects: 458